Publications
MYC protein interactors in gene transcription and cancer
http://pennlab.ca/wp-content/uploads/2021/07/Lourenco_MYC_review.png 605 482 Penn Lab Penn Lab http://pennlab.ca/wp-content/uploads/2021/07/Lourenco_MYC_review.png
Mevalonate pathway inhibition slows breast cancer metastasis via reduced N-glycosylation abundance and branching
http://pennlab.ca/wp-content/uploads/2021/02/Rosemary_Dolichol.png 396 361 Penn Lab Penn Lab http://pennlab.ca/wp-content/uploads/2021/02/Rosemary_Dolichol.png
Statins as Anticancer Agents in the Era of Precision Medicine
http://pennlab.ca/wp-content/uploads/2020/11/Screen-Shot-2020-11-05-at-12.14.41-PM.png 717 688 Penn Lab Penn Lab http://pennlab.ca/wp-content/uploads/2020/11/Screen-Shot-2020-11-05-at-12.14.41-PM.png
Computational pharmacogenomics screen identifies synergistic statin-compound combinations as anti-breast cancer therapies
http://pennlab.ca/wp-content/uploads/2020/10/Screen-Shot-2020-10-02-at-11.06.43-AM.png 981 843 Penn Lab Penn Lab http://pennlab.ca/wp-content/uploads/2020/10/Screen-Shot-2020-10-02-at-11.06.43-AM.png
Cyclic AMP‐hydrolyzing phosphodiesterase inhibitors potentiate statin‐induced cancer cell death
http://pennlab.ca/wp-content/uploads/2020/08/JL_cAMP-paper.png 952 562 Penn Lab Penn Lab http://pennlab.ca/wp-content/uploads/2020/08/JL_cAMP-paper.png
The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma
http://pennlab.ca/wp-content/uploads/2020/07/JL_t414-paper_cropped.png 295 211 Penn Lab Penn Lab http://pennlab.ca/wp-content/uploads/2020/07/JL_t414-paper_cropped.png